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ICAbstractBackground: Mast cells are one of the characteristic factors in angiogenesis, growth, and metastatic spread of
tumors. Further studies are suggested to determine the type of these cells which might be useful in the assessment
of biological nature of the tumor and its future treatment modality. Few studies have evaluated mast cell infiltration
in visceral tumors, especially uterine tumors.
Case presentation: In this study, age, sex, death rate, and histologic patterns were in agreement with those of
previous reports on canine mast cell tumors. Cytopathology assays are widely used to prognosticate canine uterine
mast cell tumors (MCT). There is limited information about these prognostic assays used on MCT that arise in the
uterine. The anisocytosis and anisocytosis and giant cells were present in the tumor. Furthermore, the tumor had
nuclear atypia with scattered multinucleated cells and prominent nucleoli and tumor were classified as poorly
granulated. Under microscopic examination, we observed diffuse infiltration and proliferation of tumor cells from
the uterine different area and the infiltrative characteristics and distribution patterns of neoplastic cells were
observed. This tumor consisted of sheets and cords of uniform round cells with discrete cytoplasmic margins.
Microscopically, the neoplastic masses were poorly-demarcated and lacked capsules and tumor cell usually showed
a distinct cell boundary. Nevertheless, the neoplastic cells were located between collagen bundles forming small
clusters and sheets and had large, centrally located, round to ovoid nuclei. In addition, eosinophils were scattered
among the mast cells at the periphery of the masses. The presence of eosinophils and the observation, at high
magnification, of cells with cytoplasmic metachromatic granules.
Conclusion: Based on these findings, a diagnosis of poorly-differentiated mast cell tumor was made and data
histologic grading was available for tumor. Neoplasm was poorly differentiated or gradeIII.
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RBackgroundEpithelial uterine neoplasia is the most lethal gynaeco-
logical malignancy in the today world and advanced dis-
ease remains incurable for the majority of patients.
Recent insights have indicated that uterine cancer is a
collective term for invasive pelvic cancers that are de-
rived from multifarious tissues with distinct histological
and epidemiological features [1-3].R
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reproducibility problems lead to as much as 50–60% dis-
cordance between experienced pathologists [2,4-7].
MCTs are among the most frequent types of dog neo-
plasms, representing approximately 20% of the skin tu-
mors and it is a usual tumor in felines and may represent
up to 20% of all cutaneous tumors. 5 Sexual predisposition
has not been reported, and etiology has not been identi-
fied. MCTs account for 2–15% of all tumors in pets, and
are classified anatomically into cutaneous and visceral
forms [8,9]. The cutaneous form of MCTs predominates
in pets, with MCTs being the second most common skin
tumor in these animals. Cutaneous MCTs are most often
located on the head, neck and trunk and are divided
histologically into two forms: mastocytic and atypical
(previously histiocytic). The mastocytic form of the dis-
ease is the more common of the two, and is further
sub-classified into well-differentiated (previously com-
pact) or poorly differentiated (previously pleomorphic
or diffuse) forms [10-13].
Mastocytic well-differentiated (compact) tumors are
circumscribed, non-encapsulated masses that consist of
solid sheets of uniform round cells with little mitotic ac-
tivity. These are the most common histological type, ac-
counting for 60% of feline cutaneous MCTs in one
review. Mastocytic poorly differentiated (pleomorphic)
MCTs are less common, accounting for <28% of all fe-
line cutaneous MCTs. They are characterized by pleo-
morphism, mononuclear or multinucleated giant cells
and infiltrate the dermis and subcutis. This variant com-
monly contains eosinophils. The majority have a very
low mitotic rate (<1 mitosis per 10 high power fields).
The mitotic rate appears to be prognostic in this subset
of feline cutaneous MCTs, as those cats with poorly dif-
ferentiated tumors with a high mitotic rate have a more
behaviorally malignant disease [12,14-16].
Visceral MCTs most often affect the spleen, account-
ing for 15–26% of splenic disease in pets [17,18]. The
alimentary tract is another common location for visceral
tumors, with MCTs being the third most common form
of pet intestinal neoplasia. Visceral MCTs may be associ-
ated with secondary cutaneous lesions. Other reported
non-cutaneous MC sites include the liver, lymph nodes
and nasal cavity [18-20].
Because of the high outbreak of MCTs, their variable
biological behavior, the potential fatal outcome attrib-
uted to aggressive disease or paraneoplastic syndromes,
and the costs and risks associated with treatment, accur-
ate prognostication of MCTs is critical [21-25]. Cyto-
pathologic examination is a low-cost, rapid, and simple
method for the diagnosis of cutaneous neoplasms [6,8].
However, there are no objective criteria for the cytologic
grading of MCTs alone regarding malignancy, which
forces clinicians and surgeons to submit tissue fragments




aim of this report was to the evaluation of the uterine
MCT with cytology and histopathology methods for the
first time in a visceral organ with an accurate diagnosis
Case presentation
Animal ethics
The animal was placed in shade, in standard conditions,
water ad libitum, and without restriction of movement
according to the guidelines of Institutional Animal Eth-
ical Committee of the Animal Science, Iran. Surgery was
performed under aseptic conditions and sedation by in-
jection of Xylazine hydrochloride (0.05 mg/kg) followed
by 2% Lignocaine hydrochloride.
In August 2014, a 4-year-old, 6 kg, female black terrier
that was presented to a private clinic for evaluation of a
3- 3.7 cm–diameter, red to white, firm nodules with ad-
herent crusts and had a sunken appearance at the right
dorsolateral aspect of the uterine. The largest mass mea-
sured 3.7 cm in diameter, while the smaller mass was
3.0 cm in diameter. Neither ulceration nor hemorrhage
was observed. The mass was surgically resected and an
impression smear of the tissue was prepared and stained
with Giemsa. The rest of the tissue was subjected to his-
topathologic evaluation. The cytopathology smear was
prepared and one of the smears was air dried and stained
with hematoxylin and eosin (HE). Fine needle aspirates of
the uterus was aspirated and interpreted at the clinic as
containing numerous, poorly-differentiated mast cells.
Complete blood cell count and serum biochemical profiles
were not performed; thoracic radiographs and abdominal
ultrasound were normal. An incisional biopsy specimen
was submitted for histopathologic examination.
At autopsy, all uterine sample was initially fixed in
buffered formalin (not exceeding 4% formaldehyde) prior
to embedding in paraffin. The neoplasm was fixed in
10% formaldehyde and routinely processed for histo-
pathology. Two 5-μm sections were obtained from each
tumor, stained with H&E, and submitted to two experi-
enced pathologist for histopathologic grading according
to previously published guidelines. The final diagnosis
was established by consensus of 2 or more observers.
Tumor was classified independently by two patholo-
gists in order to confirm the diagnosis according to the
WHO criteria [16]. Also tumor was graded according to
the criteria proposed by Patnaik et al. [5] and Kiupel
et al. [26], as well, moderately or poorly differentiated
(grades I, II or III, respectively) [5,26]. These criteria in-
cluded the following histomorphological features: extent
of tumor (invasiveness), cellular morphology, size of
cytoplasmic granules, mitotic activity and stromal reac-
tion. Invasiveness was assessed as follows: non-invasive
(tumors confined to the superficial dermis and inter-
follicular spaces); moderately invasive (tumors with lower
dermal and limited subcutaneous tissue invasion); highly
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and deep tissue). Mitotic activity was assessed on toluidine
blue-stained sections, five high power fields (hpfs) being
evaluated in each case with a × 40 objective. The data were
expressed as mean number of mitoses per hpf (mitotic
index) and tumors were classified according to the follow-
ing grading system: 0 (mitotic figures absent); 1 (mitotic
index ranging from 0 to 2 mitoses/hpf); 2 (mitotic index >
2/hpf). Invasiveness and mitotic activity assessment were
used to define the histological grade, and also as individu-
ally evaluated parameters.
Criteria for inclusion in the present study included the
availability of cytopathologic and histopathologic samples
for morphometric analysis, confirmation of the MCT
diagnosis
Cytology and histopathology findings
The anisocytosis and anisocytosis and giant cells were
present in the tumor. Furthermore, the tumor had nu-
clear atypia with scattered multinucleated cells and
prominent nucleoli and tumor were classified as poorly
granulated. They comprised solid sheets of large polyg-
onal to round-shaped cells with large vesicular nuclei,
occasionally slightly indented and also, pleomorphic cells
had significantly higher (Figure 1).





Figure 1 Fine-needle aspirate smear of a mast cell tumor, uterus; dog
Mastocytic pleomorphic types: Moderate to marked pleomorphism and ab




Under microscopic examination, we observed diffuse in-
filtration and proliferation of tumor cells from the uterine
different area and the infiltrative characteristics and distri-
bution patterns of neoplastic cells were observed (Figure 2).
This tumor consisted of sheets and cords of uniform
round cells with discrete cytoplasmic margins. Microscop-
ically, the neoplastic masses were poorly-demarcated and
lacked capsules and tumor cell usually showed a distinct
cell boundary (Figures 3 and 4). Nevertheless, the neoplas-
tic cells were located between collagen bundles forming
small clusters and sheets and had large, centrally located,
round to ovoid nuclei. In the some cells, the nuclei had
scattered or dense chromatin with small distinct nucleoli
and the nuclei had reticulated with two or three small
nucleoli visible. High - powered fields contained the
high mitotic figures (Figures 3 and 4). The neoplastic
cells had moderate amounts of finely granular cyto-
plasm and distinct cellular boundaries. Moreover, thin
or thick fibrous stroma was observed in the some of
tumor. Changes in blood vessels and presence and dis-
tribution of eosinophils and other inflammatory cells
were seen. Eosinophil infiltration was present in tumor
and lymphoplasmacytic infiltration of the uterine par-
enchyma was sharply demarcated (Figure 5). Poorly
MCTs had numerous eosinophils, significantly more
than in pleomorphic MCTs. Based on these findings, a
diagnosis of poorly-differentiated mast cell tumor was. There are many large round cells with centrally placed round nuclei,
undant infiltrate of small lymphocytes and at high magnification,





Figure 2 Histopathology of a tumoral mass from the uterine
of the dog. Neoplastic mast cells form dense sheets within
the intraparenchymal uterus. Hematoxylin and eosin stain, ×200.
Bar = 100 μm.
Figure 4 Photomicrograph of a poor-circumscribed canine
uterus mast cell tumor. Mitotic index is recorded as the number of
mitotic figures. Neoplastic mast cells are arranged as single cells,
loose aggregates, and rows linearly arranged along collagen fibers,
as supported by abundant collagenous stroma interspersed with
eosinophils Hematoxylin and eosin, ×400. Bar =10 μm.
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made and data histologic grading was available for
tumor. Neoplasm was poorly differentiated or grade III.
Discussion
Mast cell tumors (MCTs) are common in many animal




Figure 3 Uterine mast cell tumor, dog. Pleomorphic, round to
spindle cells containing a variably sized nucleus are observed.
Infiltration of eosinophils is prominent together with mitotic figures.
Hematoxylin and eosin, ×400. Bar =10 μm.Dmulticentric and may occasionally involve internal vis-cera such as the spleen, the liver, or the intestine [4].
Furthermore, in canine, MCTs most commonly occur as
skin masses and tend to metastasize to local lymph
nodes and internal organs, such as spleen and liver [27].Figure 5 Uterine; dog; mast cell tumor. Note the tumor cells are
numerous eosinophilic granulocytes that eosinophils are present at
the periphery of the tumor cells that arranged in sheets within a
scant pre-existing collagenous stroma and granular cytoplasm.
Hematoxylin and eosin, ×600. Bar =10 μm.





The mean age and the breed of dog represented in this
study was similar to those in previous reports on canine
MCT [2,7,9-11,28]. The predominance of females with
mast cell tumors, although not statistically significant,
agrees with findings in one report [29]. Other researchers
have indicated no sex difference in the incidence of these
tumors [5,28,30]. The distribution of mast cell tumors and
incidence of metastasis were similar to previous finding
[5,31]. However, one report showed a higher percentage of
dogs with met astatic mast cell tumors, possibly reflecting
a different duration of the disease.I5. In our study the
incidence of canine mast cell tumor is similar to other
species [32,33]. Our morphologic findings, tumor distri-
bution, and age at diagnosis were similar to previous re-
ports [32,34,35].
Several grading systems have been proposed to classify
canine mast cell tumors. The system most commonly
used classifies the tumor from grades I to III, depending
on how well the mast cells are differentiated, mitotic ac-
tivity, location within the skin, invasiveness, and the
presence of inflammation or necrosis, with grade III be-
ing the most aggressive (characterized by the presence of
undifferentiated, immature mast cells with a high poten-
tial for metastasis) [5]. In the current case, the presence
of multiple large nodules/or masses, the extension into
the uterine multifarious area, and the poorly differenti-
ated mast cells could be comparable to grade III de-
scribed for dog.
Furthermore, intratumoural microvessel density has
been evaluated in canine MCT and has been associated
with tumor recurrence and mortality [36]. In the present
study, an increase of mast cell infiltration and microves-
sel density with grade III was observed in MCT sample
by histopathology. On the other hand, the results of this
study suggest that cellular proliferation plays a signifi-
cant role in the progression of canine MCTs. Although
the results of this study confirm the results of previous
studies that have shown the prognostic significance of
cellular proliferation in canine MCTs [37-39] cellular
proliferation should not be evaluated as a single prog-
nostic factor for canine MCTs but should be evaluated
in tandem with additional prognostic indicators. Further-
more, the histologic characteristics of the MCTcells in this
affected dog was moderate to abundant cytoplasm, round
nuclei with scattered chromatin, fibrous stroma, and
eosinophil infiltration. Little necrosis was seen.
On the other hand, a subset of tumors termed poorly
differentiated have exhibited aggressive biologic behavior
[15,40]. Those tumors were described as meeting criteria
of malignancy, including anisokaryosis, anisocytosis,
nuclear pleomorphism, high mitotic rate, and uninucleated
and multinucleated giant cells. In our study, the tumor
from dog exhibited all these characteristics, including high




outcome in this cat supports the conclusions of previous
researchers that tumors meeting cytomorphologic criteria
of malignancy with high mitotic activity are behaviorally
aggressive. These findings suggests cellular pleomorphism
and mitotic index alone are indicative of aggressive behav-
ior of uterine MCT
Cytopathology often is helpful in the diagnosis of
MCTs because of the characteristic appearance of mast
cells with routine staining. As is the case with findings
from other species, Wright–Giemsa stain resulted in
more intensely stained granules in the neoplastic mast
cells
Conclusion
In the present study, highly cellular tumor presented ex-
tremely anaplastic cells with few granules that invaded
adjacent tissue, where areas of necrosis were also ob-
served. This tumor was classified as grade III and also,
the large majority of uterine MCT with cytomorphologic
features such as anisocytosis, anisokaryosis, nuclear aty-
pia, and multiple nuclei had benign biologic behavior.
High mitotic rate and cellular pleomorphism were as an
indicator of aggressive behavior. This is the first reported
case of uterine mast cell tumor in a dog supported by
cytology, and histopathology. After completely excising
the tumor, no further treatments were attempted, and
no recurrence has been noted to date.
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